Indefinite Delivery Contract SPE2DR25D6909

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded an Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical and medical supply support to the Department of Defense (DoD), United States Coast Guard, and other government agencies. The $999,999,999 IDC, which has a base period of 30 months and three 30-month option periods, will enable the procurement of brand-name, generic, and specialty pharmaceutical products, as well as medical devices, syringes, vials, and other supplies across multiple therapeutic areas. This contract serves as a primary vehicle for the DLA to obtain essential pharmaceuticals and medical commodities to support military healthcare programs globally, including normal day-to-day operations, contingency, and wartime readiness requirements. The agency plans to make multiple regional awards under this procurement, which will be a Lowest Price Technically Acceptable acquisition, with the intent to have at least three different contractors to enhance the DoD's supply chain resiliency.

This IDC is a follow-on to the DLA's Pharmaceutical Prime Vendor Global Program Generation V solicitation, which will establish prime vendor contracts to provide worldwide pharmaceutical support. The solicitation is expected to be issued in March 2024, with a 45-day open period, and will cover medical pharmaceuticals in the 6505 stock catalog/schedule and the current National Drug Code database. Both primary and backup suppliers will provide separate distribution fees for brand/generic and specialty pharmaceuticals to support normal and contingency operations globally. This unrestricted, fully competitive acquisition is intended to ensure the DoD has access to vital pharmaceuticals during times of contingency or natural disasters.